Kirsch Matthias E W, Ooka Tomonori, Zannis Kostantinos, Deux Jean-François, Loisance Daniel Y
Department of Thoracic and Cardiovascular Surgery, Hôpital Henri Mondor, Créteil, France.
Eur J Cardiothorac Surg. 2009 Jan;35(1):77-82. doi: 10.1016/j.ejcts.2008.09.011. Epub 2008 Oct 25.
Increasing patient age and improved durability of latest generation bioprostheses have stimulated the use of bioprosthetic devices in the setting of ascending aortic replacement as an alternative to mechanical valved conduits or aortic valve-sparing procedures. We performed an English literature review to assess different surgical options that have been described for bioprosthetic replacement of the ascending aorta. Reported options include: (1) composite valved conduits using a stented bioprosthesis; (2) composite valved conduits using a stentless bioprosthesis; (3) total xenopericardial valved conduits. Composite valved grafts using stented bioprostheses offer a safe and durable option for bioprosthetic replacement of the ascending aorta. Other options are of more recent use and await medium-term results.
患者年龄的增加以及最新一代生物假体耐久性的提高，促使生物假体装置在升主动脉置换术中得到应用，作为机械瓣膜管道或保留主动脉瓣手术的替代方案。我们进行了一项英文文献综述，以评估已描述的升主动脉生物假体置换的不同手术选择。报道的选择包括：（1）使用带支架生物假体的复合瓣膜管道；（2）使用无支架生物假体的复合瓣膜管道；（3）全异种心包瓣膜管道。使用带支架生物假体的复合瓣膜移植物为升主动脉生物假体置换提供了一种安全且持久的选择。其他选择是最近才开始使用的，尚需中期结果。
